🇺🇸 Geodon (Ziprasidone) in United States

70 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anxiety — 10 reports (14.29%)
  2. Nausea — 8 reports (11.43%)
  3. Alopecia — 7 reports (10%)
  4. Depression — 7 reports (10%)
  5. Headache — 7 reports (10%)
  6. Suicidal Ideation — 7 reports (10%)
  7. Asthenia — 6 reports (8.57%)
  8. Diarrhoea — 6 reports (8.57%)
  9. Dizziness — 6 reports (8.57%)
  10. Dyspnoea — 6 reports (8.57%)

Source database →

Other Psychiatry approved in United States

Frequently asked questions

Is Geodon (Ziprasidone) approved in United States?

Geodon (Ziprasidone) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Geodon (Ziprasidone) in United States?

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.